Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
収録刊行物
-
- The Lancet Diabetes & Endocrinology
-
The Lancet Diabetes & Endocrinology 9 (1), 22-31, 2021-01
Elsevier BV